Below are the top drugs-generic stocks on the NYSE and the NASDAQ in terms of cash. Salix Pharmaceuticals (NASDAQ: SLXP ) had $775.90 million in total cash and $869.10 million in total debt for the latest quarter. Mylan (NASDAQ: MYL ) had $412.67 million in total cash for the latest